NU/ICRF 500 is a novel anthracenyl-amino acid topoisomerase II catalytic inhibitor. References: Cummings J, Sumner AT, Slavotinek A, Meikle I, Macpherson JS, Smyth JF. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500. Mutat Res. 1995 Aug;344(1-2):55-62. PubMed PMID: 7565893.

纯度：≥98%

CAS：156074-08-7